Literature DB >> 2908870

Reactivity of primary biliary cirrhosis sera with a human fetal liver cDNA clone of branched-chain alpha-keto acid dehydrogenase dihydrolipoamide acyltransferase, the 52 kD mitochondrial autoantigen.

C D Surh1, D J Danner, A Ahmed, R L Coppel, I R Mackay, E R Dickson, M E Gershwin.   

Abstract

Antimitochondrial autoantibodies recognizing 68 to 74 and 50 to 52 kD inner membrane mitochondrial antigens are characteristically present in sera of patients with primary biliary cirrhosis. The biochemical identification of the antigens, however, has remained elusive. We report herein that the 52 kD antigen is the dihydrolipoamide acyltransferase of the branched-chain alpha-keto acid dehydrogenase complex. This was demonstrated by three experiments through the use of recombinant fusion protein expressed in Escherichia coli from a cDNA insert encoding the human autoantigen. First, 33 of 37 primary biliary cirrhosis patients exhibiting reactivity toward the 50 to 52 kD mitochondrial antigen by immunoblotting also showed reactivity toward the recombinant fusion protein. Second, absorption of primary biliary cirrhosis sera with recombinant fusion protein, but not with an irrelevant recombinant clone, the F-specific rat liver antigen, was effective in absorbing out reactivity against the 50 to 52 kD mitochondrial antigen but not the 68 to 74 kD antigen. Third, complete removal of reactivity toward all four different isoelectric point polypeptides at 50 to 52 kD was observed in two-dimensional gel analysis. Furthermore, primary biliary cirrhosis sera were analyzed with mitochondria from three sources, rat liver, human placenta and bovine heart, in order to compare reactivity patterns and to determine precisely the comparative molecular weights of the autoantigens in the three species. The availability of recombinant autoantigens will provide improved diagnostic tests and, more importantly, will allow definite issues in primary biliary cirrhosis to be studied, including identification of immunodominant epitopes, the significance of autoantigen recognition and the establishment of autoreactive T cell clones.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2908870     DOI: 10.1002/hep.1840090110

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  24 in total

1.  Molecular biology and the diagnosis and treatment of liver diseases.

Authors:  Howard J Worman; Lin Feng; Naoto Mamiya
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

Review 2.  Primary biliary cirrhosis: nature of autoantigens.

Authors:  M F Bassendine; S J Yeaman
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Anti-M9 antibodies in sera from patients with primary biliary cirrhosis recognize an epitope of glycogen phosphorylase.

Authors:  R Klein; P A Berg
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

Review 4.  Molecular characterization of the mitochondrial autoantigens in primary biliary cirrhosis.

Authors:  P S Leung; J Van de Water; R L Coppel; M E Gershwin
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

5.  Plasma membrane association of primary biliary cirrhosis mitochondrial marker antigen M2.

Authors:  U Sundin; K G Sundqvist
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

Review 6.  Primary biliary cirrhosis: considerations on pathogenesis based on identification of the M2 autoantigens.

Authors:  I R Mackay; M E Gershwin
Journal:  Springer Semin Immunopathol       Date:  1990

Review 7.  Recent developments in primary biliary cirrhosis: etiology and treatment.

Authors:  U Hopf; R Stemerowicz
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 8.  Autoantibodies in primary biliary cirrhosis.

Authors:  P A Berg; R Klein
Journal:  Springer Semin Immunopathol       Date:  1990

9.  The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore.

Authors:  J C Courvalin; K Lassoued; E Bartnik; G Blobel; R W Wozniak
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

10.  Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-beta2-glycoprotein I antibodies.

Authors:  L La Rosa; G Covini; C Galperin; L Catelli; N Del Papa; G Reina; A Morabito; G Balestrieri; A Tincani; M E Gershwin; P L Meroni
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.